Continuous-Flow Left Ventricular Assist Device Implantation in Patients With a Small Left Ventricle Masashi Kawabori, MD, Chitaru Kurihara, MD, Tadahisa Sugiura, MD, PhD, William E. Cohn, MD, Andrew B. Civitello, MD, O. Howard Frazier, MD, Jeffrey A. Morgan, MD The Annals of Thoracic Surgery Volume 105, Issue 3, Pages 799-806 (March 2018) DOI: 10.1016/j.athoracsur.2017.09.040 Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Survival rates after continuous-flow left ventricular assist device implantation for the full cohort: small left ventricle (LV) patients (blue line) versus non-small LV patients (red line). The Annals of Thoracic Surgery 2018 105, 799-806DOI: (10.1016/j.athoracsur.2017.09.040) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Survival rates after (A) HeartMate II implantation or (B) HeartWare HVAD implantation for small left ventricle (LV) patients (blue lines) versus non-small LV patients (red lines). The Annals of Thoracic Surgery 2018 105, 799-806DOI: (10.1016/j.athoracsur.2017.09.040) Copyright © 2018 The Society of Thoracic Surgeons Terms and Conditions